DK169162B1 - Anvendelse af antigestagener til fremstilling af lægemidler til terapi og profylakse af dysmenoréisk besvær samt til behandling af forstyrrelser og besvær fremkaldt af endometriose - Google Patents

Anvendelse af antigestagener til fremstilling af lægemidler til terapi og profylakse af dysmenoréisk besvær samt til behandling af forstyrrelser og besvær fremkaldt af endometriose Download PDF

Info

Publication number
DK169162B1
DK169162B1 DK487287A DK487287A DK169162B1 DK 169162 B1 DK169162 B1 DK 169162B1 DK 487287 A DK487287 A DK 487287A DK 487287 A DK487287 A DK 487287A DK 169162 B1 DK169162 B1 DK 169162B1
Authority
DK
Denmark
Prior art keywords
hydroxy
disorders
dimethylamino
phenyl
dysmenorrhea
Prior art date
Application number
DK487287A
Other languages
Danish (da)
English (en)
Other versions
DK487287A (da
DK487287D0 (da
Inventor
Walter Elger
Krzysztof Chwalisz
Sybille Beier
Marianne Faehnrich
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of DK487287D0 publication Critical patent/DK487287D0/da
Publication of DK487287A publication Critical patent/DK487287A/da
Application granted granted Critical
Publication of DK169162B1 publication Critical patent/DK169162B1/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
DK487287A 1986-09-26 1987-09-16 Anvendelse af antigestagener til fremstilling af lægemidler til terapi og profylakse af dysmenoréisk besvær samt til behandling af forstyrrelser og besvær fremkaldt af endometriose DK169162B1 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3633244 1986-09-26
DE19863633244 DE3633244A1 (de) 1986-09-26 1986-09-26 Antigestagene zur hemmung der uterinen prostaglandinsynthese

Publications (3)

Publication Number Publication Date
DK487287D0 DK487287D0 (da) 1987-09-16
DK487287A DK487287A (da) 1988-03-27
DK169162B1 true DK169162B1 (da) 1994-09-05

Family

ID=6310705

Family Applications (1)

Application Number Title Priority Date Filing Date
DK487287A DK169162B1 (da) 1986-09-26 1987-09-16 Anvendelse af antigestagener til fremstilling af lægemidler til terapi og profylakse af dysmenoréisk besvær samt til behandling af forstyrrelser og besvær fremkaldt af endometriose

Country Status (12)

Country Link
US (1) US5744464A (ja)
EP (1) EP0266303B1 (ja)
JP (1) JP2582088B2 (ja)
AT (1) ATE78690T1 (ja)
AU (1) AU605177B2 (ja)
DE (2) DE3633244A1 (ja)
DK (1) DK169162B1 (ja)
ES (1) ES2051766T3 (ja)
GR (1) GR3005467T3 (ja)
IE (1) IE66196B1 (ja)
IL (1) IL83967A (ja)
ZA (1) ZA877247B (ja)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3733478A1 (de) * 1987-10-01 1989-04-13 Schering Ag Antigestagen- und antioestrogenwirksame verbindungen zur geburtseinleitung und zum schwangerschaftsabbruch sowie zur behandlung gynaekologischer stoerungen und hormonabhaengiger tumore
FR2651435A1 (fr) * 1989-09-07 1991-03-08 Roussel Uclaf Nouvelle utilisation de composes anti-progestomimetiques.
FR2654337B1 (fr) * 1989-11-15 1994-08-05 Roussel Uclaf Nouvelles microspheres injectables biodegradables procede de preparation et suspensions injectables les renfermant.
DE19652408C2 (de) * 1996-12-06 2002-04-18 Schering Ag Steroidester, Verfahren zu ihrer Herstellung und ihre Verwendung zur Herstellung von Arzneimitteln
BR0014161A (pt) 1999-08-31 2002-05-21 Jenapharm Gmbh Mesoprogestinas (moduladores de receptor de progesterona) no tratamento e prevenção de distúrbios ginecológicos dependentes de hormÈnio benigno
WO2010117639A2 (en) * 2009-03-31 2010-10-14 The Texas A&M University System Inhibition of prostglandin e2 receptors for the treatment of endometriosis

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3077437A (en) * 1957-07-29 1963-02-12 George P Heckel Pregnanediol for treatment of premenstrual syndrome
US3666858A (en) * 1967-06-29 1972-05-30 Gordon Alan Hughes Utilization of gon-4-ene therapy in treatment of females and in growth stimulation
US4780461A (en) * 1983-06-15 1988-10-25 Schering Aktiengesellschaft 13α-alkyl-gonanes, their production, and pharmaceutical preparations containing same
DE3337450A1 (de) * 1983-10-12 1985-04-25 Schering AG, 1000 Berlin und 4709 Bergkamen Prostaglandine und antigestagene fuer den schwangerschaftsabbruch
DE3347126A1 (de) * 1983-12-22 1985-07-11 Schering AG, 1000 Berlin und 4709 Bergkamen 11ss-aryl-estradiene, deren herstellung und diese enthaltende pharmazeutische praeparate
DE3625315A1 (de) * 1986-07-25 1988-01-28 Schering Ag 11ss-(4-isopropenylphenyl)-estra-4,9-diene, deren herstellung und diese enthaltende pharmazeutische praeparate
DE3702383A1 (de) * 1987-01-23 1988-08-04 Schering Ag 11ss-alkinylestrene und -estradiene, deren herstellung und diese enthaltende pharmazeutische praeparate

Also Published As

Publication number Publication date
US5744464A (en) 1998-04-28
JP2582088B2 (ja) 1997-02-19
IE66196B1 (en) 1995-12-13
ATE78690T1 (de) 1992-08-15
DK487287A (da) 1988-03-27
EP0266303B1 (de) 1992-07-29
ZA877247B (en) 1988-03-28
AU605177B2 (en) 1991-01-10
ES2051766T3 (es) 1994-07-01
DE3633244A1 (de) 1988-03-31
IL83967A0 (en) 1988-02-29
IE872578L (en) 1988-03-26
JPS63101326A (ja) 1988-05-06
AU7895087A (en) 1988-03-31
DE3780757D1 (de) 1992-09-03
GR3005467T3 (ja) 1993-05-24
EP0266303A2 (de) 1988-05-04
IL83967A (en) 1992-11-15
EP0266303A3 (en) 1989-12-20
DK487287D0 (da) 1987-09-16

Similar Documents

Publication Publication Date Title
CA2157003C (en) Hormone replacement therapy
CN1315478C (zh) 用于提高体外受精后的植入率的组合物及其制药用途
US5888543A (en) Oral contraceptives
US20120015917A1 (en) Use of Estrogenic Compounds in Combination with Progestogenic Compounds in Hormone-Replacement Therapy
WO1996035453A2 (en) Endothelin antagonists and endothelin synthase inhibitors for the prevention and treatment of interine contractility disorders, preeclampsia, atherosclerotic vascular disease, hypertension and or hormone replacement therapy
US5747480A (en) Oral contraceptive
JP2018533542A (ja) 月経困難症および月経痛の管理のための方法
CA2724030A1 (en) Sequential administration of 20,20,21,21-pentafluoro-17-hydroxy-11.beta.-[4-(hydroxyacetyl) phenyl]-19-nor-17.alpha.-pregna-4,9-diene-3-one and one or more progestational hormonesfor treating gynaecological diseases
JP4883542B2 (ja) エストロゲン化合物とプロゲステロン様化合物よりなるホルモン組成物
DK169162B1 (da) Anvendelse af antigestagener til fremstilling af lægemidler til terapi og profylakse af dysmenoréisk besvær samt til behandling af forstyrrelser og besvær fremkaldt af endometriose
Zoma et al. Effects of combined use of sildenafil citrate (Viagra) and 17β-estradiol on ovine coronary and uterine hemodynamics
KR20000029537A (ko) 경구피임약
KR100755109B1 (ko) 양성 호르몬 의존성 부인과 질병의 치료 및 예방을 위한메조프로게스틴 (프로게스테론 수용체 조절물질)
Pasquale Rationale for a triphasic oral contraceptive
US20070088010A1 (en) Method of making a single-stage pharmaceutical preparation for oral therapy of dysfunctional uterine bleeding, containing ethinyl estradiol and dienogest
Elstein et al. Advances in oral hormonal contraception.
JPH08508502A (ja) 骨粗しょう症の治療方法および治療用組成物
Yuksel Perimenopause
Tarasova et al. What will change the debontirenone in contraception and replacement hormone therapy?

Legal Events

Date Code Title Description
B1 Patent granted (law 1993)
PBP Patent lapsed

Country of ref document: DK